Cliniques Universitaires Saint-Luc — Clinical Trial Site

632 Registered trials

266 Currently recruiting

Organisation

Cliniques Universitaires Saint-Luc

Location

Sint-Lambrechts-Woluwe, Belgium

Identifier

ORG-100008950

Address

Hippokrateslaan 10, Batiment 54, 1200, Belgium

Departments

-
/
#0804: Department Paediatric Neurology
#1001: Hematology – Day Hospital
#1004: oncology
#1100: Medical Oncology
#11001:Pediatric Neurology
#170: Pneumologie
#3001: Centre de malformations vasculaires congenitales
#3102: Intensive Care
#40121: Dermatology
#40756: Rhumatology
#7054: Dermatology
#9145: Dermatology
03202
0501: Oncologie Médicale
0504 Medical oncology/Institut Roi Albert II
056002: Medical oncology
1050: Urology
1102: Oncology
1201: Pediatric oncology – hematology
1301: Internal Medicine
2050: Urology
2202: Hematology
2901 : Paediatrics - Paediatric Hepatology
301: Gastro-entérologie
40756: Neurologie pédiatrique
Acute Medicine
Cancer et Hématologie adulte et pédiatrique
Cardiology
Cardiovascular Department
Center for Reproductive Medicine
Centre de procréation médicalement assistée
Chirurgie gynécologique
Clinical research
Clinique du sein / Oncology – Breast Clinic
Clinique Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc - Nefrology
Cliniques Universitaires Saint-Luc UCL Saint Luc
Congenital Vascular Malformations Department
Deparment of Medical Oncology
Department Hématologie et oncologie pédiatrique
Department of Dermatology
Department of Digestive Oncology
Department of Medical Oncology
Department of Nephrology
Department of Oncology
Department of Oncology, route 42
Department of Otolaryngology
Department of Pediatric Hemato-Oncology
Department of Pediatrics
Department of Pediatry
Department of Rheumatology
Dept of Medical Oncology/Institut Roi Albert II
Dept. of Medical Oncology
Dermatologie
Dermatology
Dermatology Department
Digestive Oncologie
Digestive Oncology
Division of Cardiology
Emergency Department
Endocrinology
Gastro Enterology
Gastro-entérologie
Gastro-Enterology
Gastroenterologist
Gastroenterology
Gastroenterology – Digestive Oncology
Gastroenterology (Pediatric)
General Internal and Infectious Diseases
General Internal Medicine and Infectious Diseases
General Medical Oncology
Gynaecology
Gynaecology-Andrology
Gyneacology and Andrology
Gynécologie
Haematology
Head of clinic of orthopeadic and traumatology
Head of theHaemostatis and Thrombosis Unit
Hématologie
Hématologie et Oncologie Pédiatrique
Hematologie Pediatrique
Hematologie voor volwassenen
Hematology
Hematology Department
Hematology oncology pediatric
Hematology, Haemostasis and Thrombosis Unit
Hematology/oncology
Hémotologie et oncologie pédiatrique
Hepato gastroenterology pediatric
Hepato-biliar-pancreas
Hepato-Gasteroenterology
Hépato-gastro-entérologie
Hepato-gastro-enterology
Hépato-gastroentérologie
Hepato-Gastroenterology
Hepatogastroenerology
Hepatogastroenterology
Hepatology
Hepatology -Gastroenterology
Infectiology
Infectiology Médecine interne
Infectious Disease and Internal Medicine
Infectious Diseases
Institut Roi Albert II Cancer Center - Phase 1 Unit
Intensive Care
Intensive Care Unit
Internal medicine
Internal Medicine and Infectious Disease
Internal medicine and Infectious diseases
Interstitial lung diseases
Médecine physique et réadaptation
Medical Oncology
Medical oncology (Institut Roi Albert II)
Medical Oncology Department
medical oncology/ Institut Roi Albert II
Medical Oncology/Institut Roi Albert II
Medical onocology
Melanoma department
N/A
NA
Neonatology
Néphrologie Pédiatrique
Nephrology
Nephrology department
Nephropediatrics
Neurologie
Neurology
Neurology department
Nuclear Medicine
Oncologie
Oncologie Médicale
Oncologie médicale (Medical Oncology)
Oncologie médicale/ Medical Oncology
Oncology
Oncology and Gasto-Enterology Department
Oncology Department
Oncoogy
Ophthalmology
ORL
Orthopedics
Orthopedics and Musculoskeletal Traumatology
Otorhinolaringologie
Otorhinolaryngology Department
Paediatric Department
Paediatric haemato oncology
Paediatric haemato-oncology
Paediatric Haematology and oncology
Paediatric hemato-oncology
Paediatrics
Paediatry
Pediatric Cardiology
Pediatric Department
Pediatric Endocrinology
Pediatric gastroenterology
Pediatric Gastroenterology and Hepatology
Pediatric hemato-oncology
Pediatric hemato-oncology department
Pediatric hematology and oncology
Pediatric Neurology
Pediatric Oncology and Hematology
Pediatrics
Pneumolgy
Pneumology
Pneumology Department
Pneumology, level -2
Psychiatry
Pulmonary Medicine
Pulmonology
Radiotherapist
Radiotherapy
Radiotherapy-oncology
Respiratory oncology
Rheumatology
Route 608, level -2
Service d'oncologie médicale
Service d'Orthodontie et de Parodontologie
Service de chirurgie et transplantation abdominale
Service de Dermatologie
Service de Dermatology
Service de gastro-entérologie pédiatrique
Service de neurologie
Service de pneumologie
Service oncologie médicale
UC Louvain Brussels / Department of Pediatrics
UCL Saint Luc (#1)
Unité d'Oncologie Médicale
Urology
Urology & Physiology
Urology department
Urology-Oncology

Clinical trials at this site (632)

Search interface

This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting

2023-505277-32-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2023-01-26
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
The SEAMARK Study: Phase 2 Study of First-line Encorafenib and Cetuximab Plus Pembrolizumab in Participants With BRAF V600E-mutant,MSIH/dMMR… Recruiting

2024-512119-34-00 MSI-H/dMMR metastatic colorectal cancer 4 2022-06-20
OPEN LABEL, MAINTENANCE STUDY OF ORAL TOFACITINIB IN CHILDREN WITH MODERATE TO SEVERE ULCERATIVE COLITIS Recruiting

2023-509694-22-00 Ulcerative Colitis (UC) 5 2022-01-26
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib in RET fusion-Positive NSCLC Recruiting

2023-506784-33-00 RET fusion-Positive NSCLC 5 2021-01-19
A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Parsacl… Recruiting

2022-501687-18-00 Advanced malignancies and IAI diseases 4 2020-10-28
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Acute Lymphoblastic Leukaemia 10 2014-03-27
A Phase 3 Study of I-DXd in Subjects with Relapsed SCLC Recruiting

2023-509628-16-00 Small Cell Lung Cancer (SCLC) 5 2026-05-07
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting

2025-523123-22-00 Chronic Kidney Disease 5 2026-05-07
Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Plac… Recruiting

2023-507801-32-00 Isolated Subsegmental Pulmonary Embolism 6 2026-04-22
A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting

2024-520014-22-00 Locally advanced/metastatic urothelial carcinoma 5 2026-04-22
Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s… Recruiting

2024-519304-28-00 Multiple Sclerosis 5 2026-04-20
Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met… Recruiting

2025-523224-45-00 Untreated, Unresectable or Metastatic Colorectal Cancer 10 2026-03-30
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2026-03-24
A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting

2025-522383-33-00 Interstitial lung diseases 5 2026-03-23
A Study Testing a New Targeted Drug (TUB-040) in combination with Standard Chemotherapy for Women with Ovarian Cancer Recruiting

2025-524691-33-00 High-grade epithelial serous or endometrioid epithelial 9 2026-03-09
A trial to learn how well AZD4144 works, how safe it is, and how it moves throughout the body over time in adults with acute kidney injury c… Recruiting

2025-522232-13-00 Sepsis-associated acute kidney injury (AKI) 4 2026-03-06
A trial to learn how safe AZD0486 is and how well it works in older or physically weak adults with large B-cell lymphoma when given after R-… Recruiting

2025-522029-37-00 Large B-cell Lymphoma 5 2026-02-27
Radiopharmaceutical treatment of advanced kidney cancer Recruiting

2024-517899-38-00 Clear Cell Renal Cell Carcinoma (ccRCC) 4 2026-02-25
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24
A Phase 2, Randomized, Open-Label Study Of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host… Recruiting

2025-521849-25-00 Chronic Graft-Versus-Host Disease 4 2026-02-17
A Global Phase III Study of Puxitatug Samrotecan (AZD8205) Monotherapy Compared with Physician’s Choice of Chemotherapy for B7-H4-Selected E… Recruiting

2024-518777-34-00 B7-H4-Selected Advanced/Metastatic Endometrial Cancer. 5 2026-02-11
Phase 2 Study of INCB123667 in Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression Recruiting

2025-521513-14-00 Ovarian Cancer 4 2026-02-10
To Study the Effect of Inavolisib in Combination with Fulvestrant in Participants with Breast Cancer Recruiting

2025-522805-39-00 Phosphatidylinositol-4,5-bisphosphate 3-kinase catalyti 4 2026-02-06